SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$2,371,149
-54.4%
27,850
-55.7%
0.09%
-28.1%
Q1 2023$5,203,486
-10.6%
62,882
-15.0%
0.12%
+21.0%
Q4 2022$5,817,976
+6.2%
73,9730.0%0.10%
+7.5%
Q3 2022$5,476,000
+24.1%
73,973
+6.0%
0.09%
+8.1%
Q1 2022$4,412,000
+11.9%
69,787
-6.1%
0.09%
-16.5%
Q4 2021$3,943,000
+22.9%
74,347
+63.6%
0.10%
+74.6%
Q3 2021$3,207,000
+427.5%
45,437
+397.7%
0.06%
+436.4%
Q2 2021$608,000
-62.8%
9,129
-38.0%
0.01%
-60.7%
Q1 2021$1,635,00014,7270.03%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders